| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_743e1f4d87d8b6f1ccd9739cf1ad766a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce3c28b6813dc52c9c4197ca7e5115c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73d89d61424bd381771fa6a3101741db |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-81 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70539
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
2004-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76e6db417a6fcbcc558ead1cc757774d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8eda49af51ee6f0d5b0be92a9850a885
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b52871b5724169fa1cc1231c5a3e3d94 |
| publicationDate |
2009-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2009010943-A1 |
| titleOfInvention |
Peptides associated with HLA-DR MHC class II molecule and involved in Rheumatoid arthritis |
| abstract |
Antigenic peptides that bind to MHC Class II molecules with the shared epitope referred to as HLA-DR molecules are disclosed. More specifically, are citrullinated antigenic peptides having an increased affinity for HLA-DR molecules and associated with Rheumatoid Arthritis. These novel peptides provide the basis for new methods of diagnosis and treatment of Rheumatoid Arthritis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015125944-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022189775-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022255929-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9778257-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8999921-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009155822-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012225820-A1 |
| priorityDate |
2003-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |